nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—migraine—Prednisone—atopic dermatitis	0.747	1	CpDpCtD
Zolmitriptan—Syncope—Triamcinolone—atopic dermatitis	0.000105	0.000467	CcSEcCtD
Zolmitriptan—Vertigo—Methylprednisolone—atopic dermatitis	0.000105	0.000467	CcSEcCtD
Zolmitriptan—Syncope—Methylprednisolone—atopic dermatitis	0.000105	0.000466	CcSEcCtD
Zolmitriptan—Discomfort—Hydrocortisone—atopic dermatitis	0.000104	0.000465	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Prednisone—atopic dermatitis	0.000104	0.000464	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000104	0.000462	CcSEcCtD
Zolmitriptan—Oedema—Prednisolone—atopic dermatitis	0.000104	0.000462	CcSEcCtD
Zolmitriptan—Vomiting—Tacrolimus—atopic dermatitis	0.000103	0.00046	CcSEcCtD
Zolmitriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000103	0.000458	CcSEcCtD
Zolmitriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000103	0.000457	CcSEcCtD
Zolmitriptan—Rash—Tacrolimus—atopic dermatitis	0.000102	0.000456	CcSEcCtD
Zolmitriptan—Dermatitis—Tacrolimus—atopic dermatitis	0.000102	0.000456	CcSEcCtD
Zolmitriptan—Shock—Prednisolone—atopic dermatitis	0.000102	0.000455	CcSEcCtD
Zolmitriptan—Cough—Triamcinolone—atopic dermatitis	0.000102	0.000454	CcSEcCtD
Zolmitriptan—Headache—Tacrolimus—atopic dermatitis	0.000102	0.000453	CcSEcCtD
Zolmitriptan—Oedema—Hydrocortisone—atopic dermatitis	0.000101	0.000451	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000101	0.000451	CcSEcCtD
Zolmitriptan—Convulsion—Triamcinolone—atopic dermatitis	0.000101	0.000451	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisolone—atopic dermatitis	0.000101	0.000451	CcSEcCtD
Zolmitriptan—Convulsion—Methylprednisolone—atopic dermatitis	0.000101	0.00045	CcSEcCtD
Zolmitriptan—Hypertension—Triamcinolone—atopic dermatitis	0.000101	0.000449	CcSEcCtD
Zolmitriptan—Hypertension—Methylprednisolone—atopic dermatitis	0.000101	0.000448	CcSEcCtD
Zolmitriptan—Infection—Hydrocortisone—atopic dermatitis	0.000101	0.000448	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.0001	0.000447	CcSEcCtD
Zolmitriptan—Shock—Hydrocortisone—atopic dermatitis	9.97e-05	0.000444	CcSEcCtD
Zolmitriptan—Myalgia—Triamcinolone—atopic dermatitis	9.95e-05	0.000443	CcSEcCtD
Zolmitriptan—Nervous system disorder—Hydrocortisone—atopic dermatitis	9.94e-05	0.000442	CcSEcCtD
Zolmitriptan—Myalgia—Methylprednisolone—atopic dermatitis	9.93e-05	0.000442	CcSEcCtD
Zolmitriptan—Arthralgia—Methylprednisolone—atopic dermatitis	9.93e-05	0.000442	CcSEcCtD
Zolmitriptan—Anxiety—Methylprednisolone—atopic dermatitis	9.9e-05	0.000441	CcSEcCtD
Zolmitriptan—Tachycardia—Hydrocortisone—atopic dermatitis	9.89e-05	0.00044	CcSEcCtD
Zolmitriptan—Skin disorder—Hydrocortisone—atopic dermatitis	9.84e-05	0.000438	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	9.84e-05	0.000438	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Betamethasone—atopic dermatitis	9.84e-05	0.000438	CcSEcCtD
Zolmitriptan—Discomfort—Triamcinolone—atopic dermatitis	9.84e-05	0.000438	CcSEcCtD
Zolmitriptan—Discomfort—Methylprednisolone—atopic dermatitis	9.81e-05	0.000437	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	9.8e-05	0.000436	CcSEcCtD
Zolmitriptan—Dry mouth—Triamcinolone—atopic dermatitis	9.74e-05	0.000433	CcSEcCtD
Zolmitriptan—Angioedema—Betamethasone—atopic dermatitis	9.69e-05	0.000432	CcSEcCtD
Zolmitriptan—Angioedema—Dexamethasone—atopic dermatitis	9.69e-05	0.000432	CcSEcCtD
Zolmitriptan—Anorexia—Hydrocortisone—atopic dermatitis	9.66e-05	0.00043	CcSEcCtD
Zolmitriptan—Nausea—Tacrolimus—atopic dermatitis	9.65e-05	0.00043	CcSEcCtD
Zolmitriptan—Angiopathy—Prednisone—atopic dermatitis	9.63e-05	0.000429	CcSEcCtD
Zolmitriptan—Confusional state—Methylprednisolone—atopic dermatitis	9.6e-05	0.000427	CcSEcCtD
Zolmitriptan—Immune system disorder—Prednisone—atopic dermatitis	9.59e-05	0.000427	CcSEcCtD
Zolmitriptan—Malaise—Betamethasone—atopic dermatitis	9.57e-05	0.000426	CcSEcCtD
Zolmitriptan—Malaise—Dexamethasone—atopic dermatitis	9.57e-05	0.000426	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	9.54e-05	0.000425	CcSEcCtD
Zolmitriptan—Oedema—Triamcinolone—atopic dermatitis	9.54e-05	0.000425	CcSEcCtD
Zolmitriptan—Vertigo—Dexamethasone—atopic dermatitis	9.53e-05	0.000424	CcSEcCtD
Zolmitriptan—Vertigo—Betamethasone—atopic dermatitis	9.53e-05	0.000424	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	9.52e-05	0.000424	CcSEcCtD
Zolmitriptan—Syncope—Betamethasone—atopic dermatitis	9.51e-05	0.000424	CcSEcCtD
Zolmitriptan—Syncope—Dexamethasone—atopic dermatitis	9.51e-05	0.000424	CcSEcCtD
Zolmitriptan—Arrhythmia—Prednisone—atopic dermatitis	9.48e-05	0.000422	CcSEcCtD
Zolmitriptan—Infection—Triamcinolone—atopic dermatitis	9.48e-05	0.000422	CcSEcCtD
Zolmitriptan—Infection—Methylprednisolone—atopic dermatitis	9.46e-05	0.000421	CcSEcCtD
Zolmitriptan—Shock—Triamcinolone—atopic dermatitis	9.39e-05	0.000418	CcSEcCtD
Zolmitriptan—Insomnia—Prednisolone—atopic dermatitis	9.39e-05	0.000418	CcSEcCtD
Zolmitriptan—Shock—Methylprednisolone—atopic dermatitis	9.37e-05	0.000417	CcSEcCtD
Zolmitriptan—Nervous system disorder—Methylprednisolone—atopic dermatitis	9.34e-05	0.000416	CcSEcCtD
Zolmitriptan—Loss of consciousness—Betamethasone—atopic dermatitis	9.33e-05	0.000415	CcSEcCtD
Zolmitriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	9.33e-05	0.000415	CcSEcCtD
Zolmitriptan—Paraesthesia—Prednisolone—atopic dermatitis	9.32e-05	0.000415	CcSEcCtD
Zolmitriptan—Tachycardia—Triamcinolone—atopic dermatitis	9.31e-05	0.000415	CcSEcCtD
Zolmitriptan—Tachycardia—Methylprednisolone—atopic dermatitis	9.29e-05	0.000414	CcSEcCtD
Zolmitriptan—Skin disorder—Methylprednisolone—atopic dermatitis	9.25e-05	0.000412	CcSEcCtD
Zolmitriptan—Erythema—Prednisone—atopic dermatitis	9.24e-05	0.000411	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	9.23e-05	0.000411	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	9.23e-05	0.000411	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	9.2e-05	0.00041	CcSEcCtD
Zolmitriptan—Convulsion—Betamethasone—atopic dermatitis	9.19e-05	0.000409	CcSEcCtD
Zolmitriptan—Convulsion—Dexamethasone—atopic dermatitis	9.19e-05	0.000409	CcSEcCtD
Zolmitriptan—Insomnia—Hydrocortisone—atopic dermatitis	9.17e-05	0.000408	CcSEcCtD
Zolmitriptan—Hypertension—Betamethasone—atopic dermatitis	9.16e-05	0.000408	CcSEcCtD
Zolmitriptan—Hypertension—Dexamethasone—atopic dermatitis	9.16e-05	0.000408	CcSEcCtD
Zolmitriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	9.1e-05	0.000405	CcSEcCtD
Zolmitriptan—Myalgia—Dexamethasone—atopic dermatitis	9.03e-05	0.000402	CcSEcCtD
Zolmitriptan—Myalgia—Betamethasone—atopic dermatitis	9.03e-05	0.000402	CcSEcCtD
Zolmitriptan—Anxiety—Dexamethasone—atopic dermatitis	9e-05	0.000401	CcSEcCtD
Zolmitriptan—Anxiety—Betamethasone—atopic dermatitis	9e-05	0.000401	CcSEcCtD
Zolmitriptan—Discomfort—Dexamethasone—atopic dermatitis	8.92e-05	0.000397	CcSEcCtD
Zolmitriptan—Discomfort—Betamethasone—atopic dermatitis	8.92e-05	0.000397	CcSEcCtD
Zolmitriptan—Dyspepsia—Hydrocortisone—atopic dermatitis	8.92e-05	0.000397	CcSEcCtD
Zolmitriptan—Pain—Prednisolone—atopic dermatitis	8.87e-05	0.000395	CcSEcCtD
Zolmitriptan—Decreased appetite—Hydrocortisone—atopic dermatitis	8.81e-05	0.000392	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	8.75e-05	0.00039	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	8.69e-05	0.000387	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	8.68e-05	0.000386	CcSEcCtD
Zolmitriptan—Pain—Hydrocortisone—atopic dermatitis	8.67e-05	0.000386	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	8.66e-05	0.000385	CcSEcCtD
Zolmitriptan—Oedema—Dexamethasone—atopic dermatitis	8.66e-05	0.000385	CcSEcCtD
Zolmitriptan—Oedema—Betamethasone—atopic dermatitis	8.66e-05	0.000385	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Betamethasone—atopic dermatitis	8.66e-05	0.000385	CcSEcCtD
Zolmitriptan—Insomnia—Triamcinolone—atopic dermatitis	8.63e-05	0.000384	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—NPS—atopic dermatitis	8.63e-05	0.00302	CbGpPWpGaD
Zolmitriptan—Insomnia—Methylprednisolone—atopic dermatitis	8.61e-05	0.000383	CcSEcCtD
Zolmitriptan—Infection—Dexamethasone—atopic dermatitis	8.6e-05	0.000383	CcSEcCtD
Zolmitriptan—Infection—Betamethasone—atopic dermatitis	8.6e-05	0.000383	CcSEcCtD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CCR5—atopic dermatitis	8.58e-05	0.003	CbGpPWpGaD
Zolmitriptan—Ill-defined disorder—Prednisone—atopic dermatitis	8.57e-05	0.000382	CcSEcCtD
Zolmitriptan—Paraesthesia—Triamcinolone—atopic dermatitis	8.57e-05	0.000381	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR3—atopic dermatitis	8.55e-05	0.00299	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Prednisolone—atopic dermatitis	8.55e-05	0.000381	CcSEcCtD
Zolmitriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	8.55e-05	0.000381	CcSEcCtD
Zolmitriptan—Shock—Betamethasone—atopic dermatitis	8.52e-05	0.000379	CcSEcCtD
Zolmitriptan—Shock—Dexamethasone—atopic dermatitis	8.52e-05	0.000379	CcSEcCtD
Zolmitriptan—Dyspnoea—Triamcinolone—atopic dermatitis	8.51e-05	0.000379	CcSEcCtD
Zolmitriptan—Nervous system disorder—Dexamethasone—atopic dermatitis	8.49e-05	0.000378	CcSEcCtD
Zolmitriptan—Nervous system disorder—Betamethasone—atopic dermatitis	8.49e-05	0.000378	CcSEcCtD
Zolmitriptan—Agitation—Prednisone—atopic dermatitis	8.49e-05	0.000378	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Dexamethasone—atopic dermatitis	8.48e-05	0.000377	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Betamethasone—atopic dermatitis	8.48e-05	0.000377	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCR3—atopic dermatitis	8.46e-05	0.00296	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	8.45e-05	0.00295	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	8.45e-05	0.00295	CbGpPWpGaD
Zolmitriptan—Tachycardia—Betamethasone—atopic dermatitis	8.45e-05	0.000376	CcSEcCtD
Zolmitriptan—Tachycardia—Dexamethasone—atopic dermatitis	8.45e-05	0.000376	CcSEcCtD
Zolmitriptan—HTR1B—GPCR ligand binding—NPS—atopic dermatitis	8.45e-05	0.00295	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—TAC1—atopic dermatitis	8.45e-05	0.00295	CbGpPWpGaD
Zolmitriptan—Angioedema—Prednisone—atopic dermatitis	8.44e-05	0.000376	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL27—atopic dermatitis	8.43e-05	0.00295	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	8.43e-05	0.00295	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Triamcinolone—atopic dermatitis	8.4e-05	0.000374	CcSEcCtD
Zolmitriptan—Dyspepsia—Methylprednisolone—atopic dermatitis	8.38e-05	0.000373	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	8.37e-05	0.000373	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	8.37e-05	0.000373	CcSEcCtD
Zolmitriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	8.35e-05	0.000372	CcSEcCtD
Zolmitriptan—Malaise—Prednisone—atopic dermatitis	8.33e-05	0.000371	CcSEcCtD
Zolmitriptan—Vertigo—Prednisone—atopic dermatitis	8.3e-05	0.00037	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—CCR5—atopic dermatitis	8.29e-05	0.0029	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	8.29e-05	0.0029	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	8.29e-05	0.000369	CcSEcCtD
Zolmitriptan—Syncope—Prednisone—atopic dermatitis	8.29e-05	0.000369	CcSEcCtD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	8.28e-05	0.0029	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.28e-05	0.0029	CbGpPWpGaD
Zolmitriptan—Anorexia—Dexamethasone—atopic dermatitis	8.25e-05	0.000367	CcSEcCtD
Zolmitriptan—Anorexia—Betamethasone—atopic dermatitis	8.25e-05	0.000367	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	8.25e-05	0.00289	CbGpPWpGaD
Zolmitriptan—Urticaria—Prednisolone—atopic dermatitis	8.24e-05	0.000367	CcSEcCtD
Zolmitriptan—Pain—Triamcinolone—atopic dermatitis	8.16e-05	0.000363	CcSEcCtD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	8.13e-05	0.00284	CbGpPWpGaD
Zolmitriptan—Loss of consciousness—Prednisone—atopic dermatitis	8.12e-05	0.000362	CcSEcCtD
Zolmitriptan—Urticaria—Hydrocortisone—atopic dermatitis	8.05e-05	0.000358	CcSEcCtD
Zolmitriptan—Abdominal pain—Hydrocortisone—atopic dermatitis	8.01e-05	0.000357	CcSEcCtD
Zolmitriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	8.01e-05	0.000357	CcSEcCtD
Zolmitriptan—Convulsion—Prednisone—atopic dermatitis	8.01e-05	0.000356	CcSEcCtD
Zolmitriptan—Hypertension—Prednisone—atopic dermatitis	7.98e-05	0.000355	CcSEcCtD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.96e-05	0.00278	CbGpPWpGaD
Zolmitriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	7.89e-05	0.000351	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	7.89e-05	0.000351	CcSEcCtD
Zolmitriptan—Myalgia—Prednisone—atopic dermatitis	7.87e-05	0.00035	CcSEcCtD
Zolmitriptan—Arthralgia—Prednisone—atopic dermatitis	7.87e-05	0.00035	CcSEcCtD
Zolmitriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	7.86e-05	0.00035	CcSEcCtD
Zolmitriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	7.85e-05	0.000349	CcSEcCtD
Zolmitriptan—Anxiety—Prednisone—atopic dermatitis	7.84e-05	0.000349	CcSEcCtD
Zolmitriptan—Insomnia—Dexamethasone—atopic dermatitis	7.83e-05	0.000349	CcSEcCtD
Zolmitriptan—Insomnia—Betamethasone—atopic dermatitis	7.83e-05	0.000349	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—CCL27—atopic dermatitis	7.79e-05	0.00272	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	7.79e-05	0.000347	CcSEcCtD
Zolmitriptan—Paraesthesia—Betamethasone—atopic dermatitis	7.78e-05	0.000346	CcSEcCtD
Zolmitriptan—Paraesthesia—Dexamethasone—atopic dermatitis	7.78e-05	0.000346	CcSEcCtD
Zolmitriptan—Discomfort—Prednisone—atopic dermatitis	7.77e-05	0.000346	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR3—atopic dermatitis	7.77e-05	0.00272	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.73e-05	0.0027	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Prednisolone—atopic dermatitis	7.65e-05	0.00034	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—NPS—atopic dermatitis	7.62e-05	0.00267	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—TAC1—atopic dermatitis	7.62e-05	0.00267	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Betamethasone—atopic dermatitis	7.62e-05	0.000339	CcSEcCtD
Zolmitriptan—Dyspepsia—Dexamethasone—atopic dermatitis	7.62e-05	0.000339	CcSEcCtD
Zolmitriptan—Urticaria—Triamcinolone—atopic dermatitis	7.58e-05	0.000338	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.57e-05	0.00265	CbGpPWpGaD
Zolmitriptan—Urticaria—Methylprednisolone—atopic dermatitis	7.56e-05	0.000337	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL17—atopic dermatitis	7.56e-05	0.00264	CbGpPWpGaD
Zolmitriptan—Body temperature increased—Triamcinolone—atopic dermatitis	7.54e-05	0.000336	CcSEcCtD
Zolmitriptan—Oedema—Prednisone—atopic dermatitis	7.54e-05	0.000336	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Prednisone—atopic dermatitis	7.54e-05	0.000336	CcSEcCtD
Zolmitriptan—Abdominal pain—Methylprednisolone—atopic dermatitis	7.53e-05	0.000335	CcSEcCtD
Zolmitriptan—Decreased appetite—Dexamethasone—atopic dermatitis	7.53e-05	0.000335	CcSEcCtD
Zolmitriptan—Decreased appetite—Betamethasone—atopic dermatitis	7.53e-05	0.000335	CcSEcCtD
Zolmitriptan—Infection—Prednisone—atopic dermatitis	7.49e-05	0.000334	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCR3—atopic dermatitis	7.48e-05	0.00261	CbGpPWpGaD
Zolmitriptan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	7.48e-05	0.000333	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	7.48e-05	0.000333	CcSEcCtD
Zolmitriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	7.47e-05	0.000332	CcSEcCtD
Zolmitriptan—Shock—Prednisone—atopic dermatitis	7.42e-05	0.00033	CcSEcCtD
Zolmitriptan—Pain—Betamethasone—atopic dermatitis	7.4e-05	0.00033	CcSEcCtD
Zolmitriptan—Pain—Dexamethasone—atopic dermatitis	7.4e-05	0.00033	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	7.4e-05	0.00259	CbGpPWpGaD
Zolmitriptan—Nervous system disorder—Prednisone—atopic dermatitis	7.4e-05	0.000329	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisone—atopic dermatitis	7.36e-05	0.000328	CcSEcCtD
Zolmitriptan—Skin disorder—Prednisone—atopic dermatitis	7.32e-05	0.000326	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisone—atopic dermatitis	7.29e-05	0.000325	CcSEcCtD
Zolmitriptan—Asthenia—Hydrocortisone—atopic dermatitis	7.27e-05	0.000324	CcSEcCtD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	7.25e-05	0.00254	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	7.22e-05	0.00252	CbGpPWpGaD
Zolmitriptan—Anorexia—Prednisone—atopic dermatitis	7.19e-05	0.00032	CcSEcCtD
Zolmitriptan—Pruritus—Hydrocortisone—atopic dermatitis	7.17e-05	0.000319	CcSEcCtD
Zolmitriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	7.14e-05	0.000318	CcSEcCtD
Zolmitriptan—Feeling abnormal—Betamethasone—atopic dermatitis	7.14e-05	0.000318	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL5—atopic dermatitis	7.09e-05	0.00248	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.08e-05	0.000315	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.08e-05	0.000315	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	7.05e-05	0.00247	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	7.03e-05	0.000313	CcSEcCtD
Zolmitriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.02e-05	0.000312	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—CCL17—atopic dermatitis	6.98e-05	0.00244	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.97e-05	0.00244	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	6.93e-05	0.000309	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—TAC1—atopic dermatitis	6.92e-05	0.00242	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—NPS—atopic dermatitis	6.92e-05	0.00242	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	6.92e-05	0.00242	CbGpPWpGaD
Zolmitriptan—Urticaria—Dexamethasone—atopic dermatitis	6.88e-05	0.000306	CcSEcCtD
Zolmitriptan—Urticaria—Betamethasone—atopic dermatitis	6.88e-05	0.000306	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.87e-05	0.000306	CcSEcCtD
Zolmitriptan—Dizziness—Prednisolone—atopic dermatitis	6.86e-05	0.000305	CcSEcCtD
Zolmitriptan—Asthenia—Triamcinolone—atopic dermatitis	6.85e-05	0.000305	CcSEcCtD
Zolmitriptan—Body temperature increased—Betamethasone—atopic dermatitis	6.85e-05	0.000305	CcSEcCtD
Zolmitriptan—Body temperature increased—Dexamethasone—atopic dermatitis	6.85e-05	0.000305	CcSEcCtD
Zolmitriptan—Abdominal pain—Dexamethasone—atopic dermatitis	6.85e-05	0.000305	CcSEcCtD
Zolmitriptan—Abdominal pain—Betamethasone—atopic dermatitis	6.85e-05	0.000305	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL10—atopic dermatitis	6.84e-05	0.00239	CbGpPWpGaD
Zolmitriptan—Asthenia—Methylprednisolone—atopic dermatitis	6.83e-05	0.000304	CcSEcCtD
Zolmitriptan—Insomnia—Prednisone—atopic dermatitis	6.82e-05	0.000304	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.82e-05	0.00238	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.8e-05	0.00238	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCR3—atopic dermatitis	6.79e-05	0.00237	CbGpPWpGaD
Zolmitriptan—Paraesthesia—Prednisone—atopic dermatitis	6.77e-05	0.000301	CcSEcCtD
Zolmitriptan—Pruritus—Triamcinolone—atopic dermatitis	6.75e-05	0.000301	CcSEcCtD
Zolmitriptan—Pruritus—Methylprednisolone—atopic dermatitis	6.74e-05	0.0003	CcSEcCtD
Zolmitriptan—Dizziness—Hydrocortisone—atopic dermatitis	6.7e-05	0.000298	CcSEcCtD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	6.7e-05	0.00234	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	6.7e-05	0.00234	CbGpPWpGaD
Zolmitriptan—Dyspepsia—Prednisone—atopic dermatitis	6.64e-05	0.000296	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.58e-05	0.0023	CbGpPWpGaD
Zolmitriptan—Decreased appetite—Prednisone—atopic dermatitis	6.56e-05	0.000292	CcSEcCtD
Zolmitriptan—Rash—Prednisolone—atopic dermatitis	6.54e-05	0.000291	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisolone—atopic dermatitis	6.54e-05	0.000291	CcSEcCtD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	6.53e-05	0.00228	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	6.51e-05	0.00029	CcSEcCtD
Zolmitriptan—Headache—Prednisolone—atopic dermatitis	6.5e-05	0.000289	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.45e-05	0.00226	CbGpPWpGaD
Zolmitriptan—Constipation—Prednisone—atopic dermatitis	6.45e-05	0.000287	CcSEcCtD
Zolmitriptan—Vomiting—Hydrocortisone—atopic dermatitis	6.44e-05	0.000287	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—IL5—atopic dermatitis	6.44e-05	0.00225	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	6.44e-05	0.00225	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	6.44e-05	0.00225	CbGpPWpGaD
Zolmitriptan—Rash—Hydrocortisone—atopic dermatitis	6.39e-05	0.000284	CcSEcCtD
Zolmitriptan—Dermatitis—Hydrocortisone—atopic dermatitis	6.38e-05	0.000284	CcSEcCtD
Zolmitriptan—Headache—Hydrocortisone—atopic dermatitis	6.35e-05	0.000283	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	6.31e-05	0.00221	CbGpPWpGaD
Zolmitriptan—Dizziness—Triamcinolone—atopic dermatitis	6.31e-05	0.000281	CcSEcCtD
Zolmitriptan—Dizziness—Methylprednisolone—atopic dermatitis	6.3e-05	0.00028	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	6.29e-05	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KIF3A—atopic dermatitis	6.22e-05	0.00218	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Prednisone—atopic dermatitis	6.21e-05	0.000277	CcSEcCtD
Zolmitriptan—Asthenia—Betamethasone—atopic dermatitis	6.21e-05	0.000277	CcSEcCtD
Zolmitriptan—Asthenia—Dexamethasone—atopic dermatitis	6.21e-05	0.000277	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.19e-05	0.00216	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Prednisone—atopic dermatitis	6.17e-05	0.000275	CcSEcCtD
Zolmitriptan—Nausea—Prednisolone—atopic dermatitis	6.16e-05	0.000274	CcSEcCtD
Zolmitriptan—Pruritus—Betamethasone—atopic dermatitis	6.13e-05	0.000273	CcSEcCtD
Zolmitriptan—Pruritus—Dexamethasone—atopic dermatitis	6.13e-05	0.000273	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL11—atopic dermatitis	6.09e-05	0.00213	CbGpPWpGaD
Zolmitriptan—Vomiting—Triamcinolone—atopic dermatitis	6.07e-05	0.00027	CcSEcCtD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	6.06e-05	0.00212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	6.06e-05	0.00212	CbGpPWpGaD
Zolmitriptan—Vomiting—Methylprednisolone—atopic dermatitis	6.05e-05	0.00027	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL10—atopic dermatitis	6.04e-05	0.00211	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	6.04e-05	0.00211	CbGpPWpGaD
Zolmitriptan—Nausea—Hydrocortisone—atopic dermatitis	6.02e-05	0.000268	CcSEcCtD
Zolmitriptan—Rash—Triamcinolone—atopic dermatitis	6.02e-05	0.000268	CcSEcCtD
Zolmitriptan—Dermatitis—Triamcinolone—atopic dermatitis	6.01e-05	0.000268	CcSEcCtD
Zolmitriptan—HTR1D—Signaling Pathways—FCER2—atopic dermatitis	6.01e-05	0.0021	CbGpPWpGaD
Zolmitriptan—Rash—Methylprednisolone—atopic dermatitis	6e-05	0.000267	CcSEcCtD
Zolmitriptan—Dermatitis—Methylprednisolone—atopic dermatitis	6e-05	0.000267	CcSEcCtD
Zolmitriptan—Urticaria—Prednisone—atopic dermatitis	5.99e-05	0.000267	CcSEcCtD
Zolmitriptan—Headache—Triamcinolone—atopic dermatitis	5.98e-05	0.000266	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	5.97e-05	0.00209	CbGpPWpGaD
Zolmitriptan—Headache—Methylprednisolone—atopic dermatitis	5.97e-05	0.000266	CcSEcCtD
Zolmitriptan—Abdominal pain—Prednisone—atopic dermatitis	5.96e-05	0.000265	CcSEcCtD
Zolmitriptan—Body temperature increased—Prednisone—atopic dermatitis	5.96e-05	0.000265	CcSEcCtD
Zolmitriptan—Diarrhoea—Dexamethasone—atopic dermatitis	5.92e-05	0.000264	CcSEcCtD
Zolmitriptan—Diarrhoea—Betamethasone—atopic dermatitis	5.92e-05	0.000264	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CCL5—atopic dermatitis	5.89e-05	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	5.88e-05	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	5.77e-05	0.00202	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	5.76e-05	0.00202	CbGpPWpGaD
Zolmitriptan—Dizziness—Dexamethasone—atopic dermatitis	5.73e-05	0.000255	CcSEcCtD
Zolmitriptan—Dizziness—Betamethasone—atopic dermatitis	5.73e-05	0.000255	CcSEcCtD
Zolmitriptan—Nausea—Triamcinolone—atopic dermatitis	5.67e-05	0.000252	CcSEcCtD
Zolmitriptan—Nausea—Methylprednisolone—atopic dermatitis	5.66e-05	0.000252	CcSEcCtD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	5.64e-05	0.00197	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL11—atopic dermatitis	5.63e-05	0.00197	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CMA1—atopic dermatitis	5.63e-05	0.00197	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL22—atopic dermatitis	5.59e-05	0.00195	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Prednisone—atopic dermatitis	5.56e-05	0.000247	CcSEcCtD
Zolmitriptan—Vomiting—Dexamethasone—atopic dermatitis	5.51e-05	0.000245	CcSEcCtD
Zolmitriptan—Vomiting—Betamethasone—atopic dermatitis	5.51e-05	0.000245	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL10—atopic dermatitis	5.49e-05	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	5.48e-05	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR3—atopic dermatitis	5.47e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	5.47e-05	0.00191	CbGpPWpGaD
Zolmitriptan—Rash—Betamethasone—atopic dermatitis	5.46e-05	0.000243	CcSEcCtD
Zolmitriptan—Rash—Dexamethasone—atopic dermatitis	5.46e-05	0.000243	CcSEcCtD
Zolmitriptan—Dermatitis—Betamethasone—atopic dermatitis	5.45e-05	0.000243	CcSEcCtD
Zolmitriptan—Dermatitis—Dexamethasone—atopic dermatitis	5.45e-05	0.000243	CcSEcCtD
Zolmitriptan—Headache—Betamethasone—atopic dermatitis	5.42e-05	0.000241	CcSEcCtD
Zolmitriptan—Headache—Dexamethasone—atopic dermatitis	5.42e-05	0.000241	CcSEcCtD
Zolmitriptan—Asthenia—Prednisone—atopic dermatitis	5.41e-05	0.000241	CcSEcCtD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	5.36e-05	0.00187	CbGpPWpGaD
Zolmitriptan—Pruritus—Prednisone—atopic dermatitis	5.34e-05	0.000238	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—CCR5—atopic dermatitis	5.3e-05	0.00185	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.3e-05	0.00185	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT6—atopic dermatitis	5.29e-05	0.00185	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.26e-05	0.00184	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCL5—atopic dermatitis	5.2e-05	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.2e-05	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	5.19e-05	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.19e-05	0.00181	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Prednisone—atopic dermatitis	5.16e-05	0.00023	CcSEcCtD
Zolmitriptan—Nausea—Dexamethasone—atopic dermatitis	5.14e-05	0.000229	CcSEcCtD
Zolmitriptan—Nausea—Betamethasone—atopic dermatitis	5.14e-05	0.000229	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	5.1e-05	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCL8—atopic dermatitis	5.01e-05	0.00175	CbGpPWpGaD
Zolmitriptan—Dizziness—Prednisone—atopic dermatitis	4.99e-05	0.000222	CcSEcCtD
Zolmitriptan—MAOA—Metabolism—GLB1—atopic dermatitis	4.98e-05	0.00174	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL27—atopic dermatitis	4.98e-05	0.00174	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR3—atopic dermatitis	4.97e-05	0.00174	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	4.88e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—NPS—atopic dermatitis	4.88e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	4.88e-05	0.0017	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	4.86e-05	0.0017	CbGpPWpGaD
Zolmitriptan—Vomiting—Prednisone—atopic dermatitis	4.79e-05	0.000213	CcSEcCtD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	4.78e-05	0.00167	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ADSL—atopic dermatitis	4.78e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	4.77e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	4.77e-05	0.00167	CbGpPWpGaD
Zolmitriptan—Rash—Prednisone—atopic dermatitis	4.75e-05	0.000212	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisone—atopic dermatitis	4.75e-05	0.000211	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—CCL5—atopic dermatitis	4.72e-05	0.00165	CbGpPWpGaD
Zolmitriptan—Headache—Prednisone—atopic dermatitis	4.72e-05	0.00021	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR5—atopic dermatitis	4.69e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	4.68e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR3—atopic dermatitis	4.59e-05	0.0016	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	4.55e-05	0.00159	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	4.53e-05	0.00158	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.49e-05	0.00157	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	4.48e-05	0.00157	CbGpPWpGaD
Zolmitriptan—Nausea—Prednisone—atopic dermatitis	4.48e-05	0.000199	CcSEcCtD
Zolmitriptan—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	4.47e-05	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	4.44e-05	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	4.43e-05	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	4.43e-05	0.00155	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.4e-05	0.00154	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.4e-05	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	4.39e-05	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	4.37e-05	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	4.34e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	4.34e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	4.34e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR5—atopic dermatitis	4.26e-05	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	4.25e-05	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.21e-05	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	4.17e-05	0.00146	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.13e-05	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.12e-05	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	4.12e-05	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TAC1—atopic dermatitis	4.09e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NPS—atopic dermatitis	4.09e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	4.08e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	4.03e-05	0.00141	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCR3—atopic dermatitis	4.01e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	3.98e-05	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	3.96e-05	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	3.95e-05	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	3.9e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	3.87e-05	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	3.82e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL5—atopic dermatitis	3.8e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	3.78e-05	0.00132	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	3.71e-05	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	3.71e-05	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	3.64e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	3.64e-05	0.00127	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.62e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	3.6e-05	0.00126	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	3.6e-05	0.00126	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.57e-05	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	3.52e-05	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	3.52e-05	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	3.51e-05	0.00123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	3.44e-05	0.0012	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	3.38e-05	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	3.38e-05	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	3.33e-05	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	3.33e-05	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	3.31e-05	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	3.3e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	3.3e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	3.26e-05	0.00114	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL10—atopic dermatitis	3.24e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	3.24e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	3.21e-05	0.00112	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.14e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	3.14e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.08e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	3.07e-05	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	3.02e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	3e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	2.97e-05	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	2.96e-05	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	2.93e-05	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	2.93e-05	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.88e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	2.87e-05	0.001	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL8—atopic dermatitis	2.83e-05	0.000991	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCL5—atopic dermatitis	2.79e-05	0.000976	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	2.72e-05	0.000952	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL2—atopic dermatitis	2.71e-05	0.000947	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	2.69e-05	0.000939	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	2.69e-05	0.000939	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	2.67e-05	0.000932	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	2.62e-05	0.000915	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	2.62e-05	0.000915	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	2.62e-05	0.000915	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NGF—atopic dermatitis	2.58e-05	0.000904	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL8—atopic dermatitis	2.57e-05	0.0009	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	2.57e-05	0.000897	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	2.56e-05	0.000895	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	2.56e-05	0.000895	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	2.52e-05	0.000883	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR5—atopic dermatitis	2.51e-05	0.000879	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	2.51e-05	0.000878	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	2.48e-05	0.000868	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL2—atopic dermatitis	2.46e-05	0.00086	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	2.43e-05	0.00085	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	2.39e-05	0.000836	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	2.38e-05	0.000833	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	2.25e-05	0.000788	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.24e-05	0.000782	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	2.19e-05	0.000765	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFKBIA—atopic dermatitis	2.13e-05	0.000745	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	2.07e-05	0.000725	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	2.03e-05	0.00071	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	2.03e-05	0.00071	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	1.95e-05	0.000682	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	1.95e-05	0.000682	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	1.91e-05	0.000669	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.84e-05	0.000643	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.81e-05	0.000634	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.000634	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.78e-05	0.000624	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.77e-05	0.00062	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.76e-05	0.000616	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	1.75e-05	0.000611	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000606	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	1.7e-05	0.000593	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.65e-05	0.000578	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000575	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	1.62e-05	0.000566	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARA—atopic dermatitis	1.62e-05	0.000566	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.61e-05	0.000563	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000562	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	1.57e-05	0.00055	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.00055	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	1.55e-05	0.000541	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	1.54e-05	0.000538	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	1.52e-05	0.000532	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—atopic dermatitis	1.45e-05	0.000508	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	1.45e-05	0.000505	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000477	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.35e-05	0.000473	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.34e-05	0.000468	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	1.34e-05	0.000468	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	1.33e-05	0.000467	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	1.33e-05	0.000465	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	1.29e-05	0.000452	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	1.23e-05	0.000431	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.23e-05	0.000429	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	1.2e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	1.17e-05	0.00041	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.02e-05	0.000356	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	9.72e-06	0.00034	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	9.52e-06	0.000333	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	9.29e-06	0.000325	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	9.24e-06	0.000323	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	9.1e-06	0.000318	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	9.05e-06	0.000316	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	8.55e-06	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—atopic dermatitis	8.54e-06	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	8.37e-06	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	7.25e-06	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	6.93e-06	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	6.9e-06	0.000241	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	6.38e-06	0.000223	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARA—atopic dermatitis	5.97e-06	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	5.46e-06	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	5.35e-06	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	4.07e-06	0.000142	CbGpPWpGaD
